Search

Your search keyword '"Parsons, Benjamin"' showing total 104 results

Search Constraints

Start Over You searched for: Author "Parsons, Benjamin" Remove constraint Author: "Parsons, Benjamin" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
104 results on '"Parsons, Benjamin"'

Search Results

1. Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit

2. A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL

5. Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial

8. Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms

10. Cancelled operations: a 7-day cohort study of planned adult inpatient surgery in 245 UK National Health Service hospitals

11. Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

12. Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples

13. XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53

14. Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy

16. Exceptional Response to Crizotinib With Subsequent Response to Cabozantinib in Metastatic, ROS1-GOPC Fusion–Mutated Breast Cancer.

17. Diffuse Large B-Cell Lymphoma Has a Low Frequency of dMMR and High Frequencies of DNA Mismatch Repair Protein High Expression Associated with Lower T-Cell Infiltration

19. Tumor-Infiltrating Normal B Lymphocytes Have Remarkable Prognostic Effects and Are Crucial for Antitumor Immune Responses in Diffuse Large B-Cell Lymphoma

26. Determining Clinical Course of Diffuse Large B-Cell Lymphoma Using Targeted Transcriptome and Machine Learning Algorithms

27. Outcomes of Primary Bone Diffuse Large B-Cell Lymphoma in the Rituximab Era: A Multicenter Retrospective Analysis

34. Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database*.

35. Fewer Reoperations After Lumpectomy for Breast Cancer with Neoadjuvant Rather than Adjuvant Chemotherapy: A Report from the National Cancer Database.

36. Exceptional Response to Crizotinib in an MET-Amplified Triple-Negative Breast Tumor.

37. Implementation and Clinical Utility of an Integrated Academic-Community Regional Molecular Tumor Board.

43. Managing cellular congestion using incentives.

49. DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphoma.

50. Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.

Catalog

Books, media, physical & digital resources